Table 3.
Features | All | Mutation Carriers | Non-Mutation Carrier | p Value |
---|---|---|---|---|
Patient No | 49 | 6 | 43 | |
Age | 43.4 ± 5.7 | 43.7 ± 5.3 | 43.4 ± 5.8 | 0.906 |
Gender | ||||
Female | 24 | 3 (13%) | 21 (87%) | 0.957 |
Male | 25 | 3 (12%) | 22 (88%) | |
Tumor TNM stage | ||||
1 | 8 | 0 (0%) | 8 (100%) | 0.237 |
2 | 10 | 1 (10%) | 9 (90%) | |
3 | 21 | 2 (9.5%) | 19 (90.5%) | |
4 | 10 | 3 (30%) | 7 (70%) | |
Tumor Location | ||||
Right colon | 10 | 3 (30%) | 7 (70%) | 0.055 |
Left colon and rectum | 39 | 3 (7.7%) | 36 (92.3%) | |
Tumor size | ||||
<5 cm | 32 | 2 (6.3%) | 30 (93.7%) | 0.079 |
≥5 cm | 17 | 4 (24%) | 13 (76%) | |
Tumor histology | ||||
Adenocarcinoma | 44 | 4 (9%) | 40 (91%) | 0.001 |
Mucinous | 3 | 0 (0%) | 3 (100%) | |
Signet ring cell | 2 | 2 (100%) | 0 (0%) | |
Tumor grade | ||||
Well | 7 | 0 (0%) | 7 (100%) | 0.334 |
Moderate | 34 | 4 (12%) | 30 (88%) | |
Poor | 8 | 2 (25%) | 6 (75%) | |
Pre_operation CEA | ||||
<5 ng/mL | 31 | 2 (6.5%) | 29 (93.5%) | 0.104 |
≥5 ng/mL | 18 | 4 (22%) | 14 (78%) | |
Recurrence (except TNM 4) | ||||
Yes | 8 | 0 (0%) | 8 (100%) | 0.360 |
No | 31 | 3 (10%) | 28 (90%) |